Arcus Biosciences
RCUS
RCUS
78 hedge funds and large institutions have $210M invested in Arcus Biosciences in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $322M → $210M (-$112M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
78
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.76M | |
| 2 | +$3.94M | |
| 3 | +$3.22M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.06M |
| 5 |
Morgan Stanley
New York
|
+$705K |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$553K | |
| 3 | -$239K | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$204K |
| 5 |
SG Americas Securities
New York
|
-$110K |